We revealed that PRKCG, a gene specifically expressed in brain and detectable in cerebrospinal fluid (CSF), is closely associated with glioma, indicative of a potential biomarker for glioma diagnosis, prognosis and treatment prediction. The gene discussed is PRKCG; the disease is central nervous system cancer.